Serlopitant

Serlopitant

SCHEMBL16280735

CC(O[C@H]1CC[C@@H]2CN(C3=CC(=O)CC3)C[C@H]2C1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

TACR1

The experimentally established mechanism targets of Serlopitant. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
TACR1 known ✓ P25103 20/20 1.00
TACR2 P21452 2/20 1.00
CYP3A4 P08684 1/20 1.00
CYP2C8 P10632 1/20 1.00
CYP2D6 P10635 1/20 1.00
CYP2C9 P11712 1/20 1.00
TACR3 P29371 1/20 1.00
CYP2C19 P33261 1/20 1.00
KCNH2 Q12809 1/20 0.58
NR1I2 O75469 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Serlopitant SCHEMBL3183159 1.00 TACR1 (1.00) TACR1TACR2CYP3A4CYP2C8CYP2D6
Serlopitant SCHEMBL16333766 1.00 TACR1 (1.00) TACR1TACR2CYP3A4CYP2C8CYP2D6
Serlopitant SCHEMBL12646287 1.00 TACR1 (1.00) TACR1TACR2CYP3A4CYP2C8CYP2D6
Serlopitant SCHEMBL24067973 1.00 TACR1 (1.00) TACR1TACR2CYP3A4CYP2C8CYP2D6
Serlopitant SCHEMBL3184271 1.00 TACR1 (1.00) TACR1TACR2CYP3A4CYP2C8CYP2D6
Serlopitant SCHEMBL23883105 1.00 TACR1 (1.00) TACR1TACR2CYP3A4CYP2C8CYP2D6
Serlopitant SCHEMBL16280736 1.00 TACR1 (1.00) TACR1TACR2CYP3A4CYP2C8CYP2D6
SCHEMBL13531608 0.95 TACR1 (0.91) TACR1TACR2CYP3A4CYP2C8CYP2D6
SCHEMBL16280639 0.95 TACR1 (0.91) TACR1TACR2CYP3A4CYP2C8CYP2D6
SCHEMBL16353223 0.95 TACR1 (0.91) TACR1TACR2CYP3A4CYP2C8CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8906951-B1 Use of NK-1 receptor antagonists in pruritus Tigercat Pharma, Inc. (US) 2014-12-09 US disclosed